PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 31, 2026Cureus0 citationsOpen Access

Biopsy-Proven Non-glomerular Renal Pathology in Localized Granulomatosis With Polyangiitis Treated With Methotrexate and Avacopan Presenting With New Renal Symptoms: A Case Report

View Full Paper
KMKaandeeban MohanrajJAJohn K. AmersonNNNaveen Punchayil Narayanankutty

Key Points

  • To highlight renal complications in a patient with granulomatosis with polyangiitis treated with methotrexate and avacopan.
  • Described a case of a patient with localized sinonasal GPA
  • Conducted renal biopsy due to new-onset urinary abnormalities
  • Performed laboratory evaluation including serum creatinine and urine protein-creatinine ratio
  • Serum creatinine level was 1.4 mg/dL
  • Urine protein-creatinine ratio was 0.96 g/g
  • Moderate hematuria and red blood cell casts were observed
  • No evidence of crescentic glomerulonephritis on biopsy
  • Avoided escalation to stronger immunosuppressive therapy by confirming histopathology

Abstract

Granulomatosis with polyangiitis (GPA) is an antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis that commonly involves the upper respiratory tract and kidneys. The development of new-onset urinary abnormalities, microscopic hematuria, and declining renal function in a patient on treatment with methotrexate and avacopan warrants a prompt renal biopsy to lead management decisions. We describe a case of localized sinonasal GPA in a patient receiving methotrexate and avacopan who presented with new renal symptoms. Laboratory evaluation revealed a serum creatinine of 1.4 mg/dL and a urine protein-creatinine ratio (UPCR) of 0.96 g/g with moderate hematuria and red blood cell casts on urine microscopy. Renal biopsy revealed no evidence of pauci-immune crescentic glomerulonephritis, highlighting the importance of histopathologic confirmation before escalation of immunosuppressive therapy. These findings prevented escalation to stronger immunosuppressive therapy and allowed continuation of the existing regimen. Moreover, the combined use of methotrexate and avacopan in nasal-limited GPA is not well documented, and this case adds more clinical understanding to this therapeutic strategy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Mohanraj et al. (2026) studied this question.

synapsesocial.com/papers/69cb645fe6a8c024954b898chttps://doi.org/10.7759/cureus.106031
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Granulomatosis With Polyangiitis (GPA): Isolated Nasal Bridge Involvement2024 · 3 citations
  2. 2KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitis2024 · 202 citations
  3. 3The Urine Sediment as a Biomarker of Kidney Disease2015 · 155 citations
  4. 4Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody–associated vasculitis2005 · 799 citations
  5. 52022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis2022 · 485 citations